Essential Thrombocythemia

Showing NaN - NaN of 11

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Myelofibrosis, Essential Thrombocythemia, MPN Trial in New York (Peptide-based vaccine, Poly ICLC)

Not yet recruiting
  • Myelofibrosis
  • +2 more
  • Peptide-based vaccine
  • Poly ICLC
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Jun 7, 2022

Essential Thrombocythemia Trial in Worldwide (IMG-7289)

Active, not recruiting
  • Essential Thrombocythemia
  • Jacksonville, Florida
  • +25 more
Apr 15, 2022

Essential Thrombocythemia Trial in Worldwide (Ropeginterferon alfa-2b, Anagrelide)

Recruiting
  • Essential Thrombocythemia
  • Phoenix, Arizona
  • +60 more
Dec 30, 2021

Polycythemia Vera, Essential Thrombocythemia Trial in Washington, New York, Winston-Salem (RG7388, Pegasys)

Completed
  • Polycythemia Vera
  • Essential Thrombocythemia
  • Washington, District of Columbia
  • +2 more
Sep 11, 2019

Research Tissue Bank

Completed
  • Myelofibrosis
  • +3 more
    • Palo Alto, California
    • +10 more
    Jul 2, 2019

    Patients With Myeloproliferative Disorders

    Completed
    • Myeloproliferative Disease
    • +4 more
      • Scottsdale, Arizona
      • +21 more
      Dec 12, 2018

      Polycythemia Vera or Essential Thrombocythemia Patients

      Completed
      • Polycythemia Vera
      • Essential Thrombocythemia
      • Blood specimen
      • New York, New York
        Icahn School of Medicine at Mount Sinai
      Jan 17, 2018

      Familial Myeloproliferative Disorders

      Completed
      • Polycythemia Vera
      • +2 more
        • Washington, D.C., District of Columbia
        • +5 more
        Sep 1, 2017

        Myelofibrosis, Essential Thrombocythemia, Polycythemia Vera Trial in United States (CEP-701 (Lestaurtinib))

        Unknown status
        • Myelofibrosis
        • +2 more
        • CEP-701 (Lestaurtinib)
        • Palo Alto, California
        • +6 more
        Nov 24, 2014

        Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic

        Completed
        • Accelerated Phase Chronic Myelogenous Leukemia
        • +84 more
        • sunitinib malate
        • +2 more
        • Los Angeles, California
        • +10 more
        Mar 14, 2014